yihQ Antibody

What is yihQ and what is its biological function?

YihQ is a sulfoquinovosidase enzyme belonging to the CAZy glycoside hydrolase family 31 (GH31) that cleaves sulfoquinovosyl diacylglyceride sulfolipids . This enzyme plays a critical role in the metabolism of sulfoquinovose (SQ), a sugar commonly found in plant sulfolipids. YihQ specifically catalyzes the hydrolysis of the glycosidic bond in sulfoquinovosides to release free sulfoquinovose . The enzyme demonstrates robust catalysis with kinetic parameters of kcat = 14.3±0.4 s⁻¹, KM = 0.22±0.03 mM, and kcat/KM = (6.4±1.0)×10⁴ M⁻¹s⁻¹ using para-nitrophenyl α-sulfoquinovoside (PNPSQ) as substrate .

What are the validated applications for yihQ antibody in research?

The yihQ antibody has been validated for the following applications:

Researchers can use these methods to:

• Detect and quantify yihQ expression in bacterial samples

• Investigate protein localization in cellular compartments

• Study protein-protein interactions involving yihQ

• Monitor yihQ expression under different growth conditions

What are the recommended storage and handling conditions for yihQ antibody?

For optimal performance and stability, yihQ antibody should be stored at -20°C or -80°C immediately upon receipt . Repeated freeze-thaw cycles should be avoided as they can lead to antibody degradation and loss of activity . The antibody is supplied in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . When working with the antibody, aliquoting into smaller volumes is recommended to minimize freeze-thaw cycles.

What are the key specifications of commercially available yihQ antibody?

Commercial yihQ antibodies have the following specifications:

How does the structure of yihQ relate to its enzymatic function?

The X-ray crystal structure of yihQ reveals an (αβ)8 barrel core appended with a small β-sheet domain . This structural arrangement is typical of GH31 family enzymes but with key differences in the active site that explain yihQ's specificity for sulfoquinovosides.

Three critical structural aspects contribute to yihQ function:

• Active site architecture: The active site contains specific residues arranged to accommodate the unique structure of sulfoquinovose, particularly the sulfonate group at the 6-position.

• Catalytic residues: As a retaining glycosidase, yihQ utilizes a double-displacement mechanism involving two catalytic residues - a nucleophile (D405) and an acid/base catalyst (D472) .

• Sulfonate recognition: The enzyme possesses a specialized binding pocket for the sulfonate group with key residues W304, R301, and Y508 that coordinate with the sulfonate group through direct hydrogen bonding or water-mediated interactions .

Comparing yihQ with sugar beet α-glucosidase (SBG) reveals significant differences in active site residues that explain yihQ's specificity for SQ over D-glucose, particularly in the regions that interact with the 4- and 6-positions of the sugar .

What methods can be used to assess yihQ antibody specificity and cross-reactivity?

To evaluate yihQ antibody specificity and potential cross-reactivity, researchers should consider the following methodological approaches:

• Western Blot Analysis with Control Samples:

  • Use wildtype E. coli K12 expressing yihQ

  • Compare with yihQ knockout strains

  • Test against closely related bacterial species

  • Include purified recombinant yihQ protein as positive control

• Immunoprecipitation-Mass Spectrometry (IP-MS):

  • Use the antibody to immunoprecipitate proteins from bacterial lysates

  • Analyze precipitated proteins by mass spectrometry

  • Identify any non-target proteins that may have been captured

• Peptide Competition Assay:

  • Pre-incubate the antibody with excess immunizing peptide/protein

  • Compare binding in standard assays with and without competition

  • Specific antibodies will show significantly reduced signal after peptide competition

• Immunofluorescence with Genetic Controls:

  • Perform immunostaining on wildtype and yihQ-deficient bacteria

  • Analyze subcellular localization patterns

  • Confirm specificity through absence of signal in knockout strains

When evaluating antibody reactivity, researchers should be aware that even highly specific antibodies may show some degree of cross-reactivity with structurally similar proteins, particularly those in the same enzyme family (GH31).

How can site-directed mutagenesis of yihQ inform antibody epitope mapping?

Site-directed mutagenesis combined with antibody binding studies can provide valuable insights into the specific epitopes recognized by yihQ antibodies. This methodological approach involves:

• Key Residue Identification:

  • Based on structural data, identify surface-exposed residues likely to be part of antibody epitopes

  • Focus on regions with high predicted antigenicity

• Systematic Mutagenesis Strategy:

  • Create single amino acid substitutions in predicted epitope regions

  • Develop mutation series where conserved residues are replaced with alanine or with residues of different characteristics (charge, size, hydrophobicity)

  • For residues already identified as functionally important, such as R301, W304, and Y508 , determine if they are also part of antibody recognition sites

• Binding Assay Protocol:

  • Express and purify wildtype and mutant yihQ proteins

  • Perform ELISA or Western blot analysis to assess antibody binding

  • Quantify binding affinity changes using surface plasmon resonance or bio-layer interferometry

  • Reduced antibody binding to specific mutants indicates involvement of the altered residue in the epitope

• Data Analysis and Interpretation:

  • Map antibody binding sites onto the 3D structure of yihQ

  • Correlate epitope regions with known functional domains

  • Assess whether antibody binding affects enzymatic activity through blocking active sites or inducing conformational changes

This approach has previously revealed that R301 is critical for sulfonate recognition, with R301A and R301E mutants having no detectable activity against PNPSQ, while the R301K mutant retained residual activity . Such findings suggest that antibodies targeting this region might interfere with substrate binding.

What experimental approaches can measure the impact of yihQ antibody binding on enzyme activity?

To determine whether yihQ antibody binding affects the enzyme's catalytic activity, researchers can employ the following methodological approaches:

• Enzyme Inhibition Assays:

  Protocol outline:

  • Prepare reaction mixtures containing:

    • Purified yihQ enzyme (10-50 nM)

    • Varying concentrations of antibody (0-1000 nM)

    • Pre-incubate for 30 minutes at 25°C

    • Add chromogenic substrate PNPSQ (0.5 mM)

    • Monitor release of p-nitrophenol at 405 nm over time

  • Plot reaction velocity vs. antibody concentration

  • Calculate IC50 and inhibition constants

• Active Site Protection Experiments:

  Protocol outline:

  • Pre-incubate yihQ with substrate (PNPSQ or SQDG)

  • Add varying concentrations of antibody

  • Measure enzyme activity

  • Compare with activity when antibody is added before substrate

  • If substrate protects against antibody inhibition, this suggests the antibody binds at or near the active site

• Surface Plasmon Resonance (SPR) Analysis:

  Protocol outline:

  • Immobilize yihQ on SPR chip

  • Flow antibody over the surface and record binding kinetics

  • In separate experiments, pre-saturate yihQ with substrate

  • Compare antibody binding kinetics with and without substrate

  • Altered binding in the presence of substrate indicates overlap between antibody epitope and substrate binding site

• Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):

  Protocol outline:

  • Expose yihQ to D2O buffer to allow hydrogen-deuterium exchange

  • Compare exchange patterns with and without antibody bound

  • Regions protected from exchange when antibody is bound represent the antibody epitope

  • Overlap between these regions and the known active site would suggest potential for functional interference

How can yihQ antibody be used to study the distribution of sulfoquinovose metabolism genes across bacterial populations?

The yihQ antibody can be employed as a powerful tool to investigate the distribution and expression of sulfoquinovose metabolism pathways across diverse bacterial communities. Methodological approaches include:

• Immunofluorescence Microscopy of Environmental Samples:

  Protocol outline:

  • Collect environmental samples (soil, water, plant surfaces)

  • Fix bacterial cells with paraformaldehyde

  • Permeabilize cell membranes

  • Incubate with yihQ antibody followed by fluorescent secondary antibody

  • Counterstain with DAPI to visualize all bacterial cells

  • Calculate the percentage of yihQ-positive cells in the population

  • Combine with FISH (Fluorescence In Situ Hybridization) to identify bacterial taxa

• Flow Cytometry Analysis of Mixed Bacterial Communities:

  Protocol outline:

  • Prepare single-cell suspensions from environmental samples

  • Fix and permeabilize cells

  • Label with yihQ antibody and fluorescent secondary antibody

  • Analyze by flow cytometry to quantify frequency of yihQ-expressing cells

  • Sort positive cells for subsequent genomic analysis

• Comparative Expression Analysis Across Bacterial Phyla:

  Protocol outline:

  • Culture diverse bacterial species under defined conditions

  • Prepare cell lysates

  • Conduct Western blot analysis with yihQ antibody

  • Normalize signal to total protein content

  • Compare expression levels across species and growth conditions

• Correlation with Genomic Presence:

  Protocol outline:

  • Perform whole-genome sequencing of antibody-positive bacterial isolates

  • Identify yihQ homologs and analyze their genomic context

  • Construct phylogenetic trees based on yihQ sequences

  • Correlate antibody reactivity with sequence conservation

Previous phylogenetic analysis has revealed that putative sulfoquinovosidases comprise their own clade within the GH31 family, suggesting that degradation of sulfoquinovosides is far more widespread than previously anticipated . This method could help identify bacteria capable of utilizing this ubiquitous source of carbon and sulfur in various ecosystems.

What controls should be included when using yihQ antibody in immunoassays?

Proper experimental controls are critical for interpreting results obtained with yihQ antibody. Researchers should include:

During validation, researchers should compare results across multiple detection methods to confirm specificity. For instance, if Western blot shows a single band of the expected molecular weight (~92 kDa for yihQ), this supports the specificity observed in ELISA or immunofluorescence assays.

How can researchers assess potential cross-reactivity with similar GH31 family enzymes?

The GH31 glycoside hydrolase family contains enzymes with α-glucosidase, α-glucan lyase, and α-xylanase activity . To evaluate potential cross-reactivity with related enzymes, researchers should:

• Sequence Homology Analysis:

  • Identify GH31 family members with sequence similarity to yihQ

  • Align sequences to identify conserved epitope regions

  • Focus particularly on regions containing the key residues R301, W304, and Y508 that may form part of antibody epitopes

• Recombinant Protein Panel Testing:

  • Express and purify related GH31 enzymes

  • Test antibody reactivity against all family members using consistent conditions

  • Create a cross-reactivity profile showing relative binding to each protein

• Domain-Specific Testing:

  • Generate constructs expressing only specific domains of yihQ

  • Test antibody binding to identify which domains contain the epitopes

  • Compare domain architecture with other GH31 enzymes

• Epitope Prediction and Validation:

  • Use computational tools to predict antibody epitopes on yihQ

  • Synthesize predicted epitope peptides

  • Test antibody binding to these peptides

  • Evaluate whether similar peptide sequences exist in other proteins

A study of putative sulfoquinovosidases across diverse organisms revealed that these enzymes comprise their own clade within the GH31 family , suggesting structural distinctions that may be recognized by specific antibodies.

What techniques can be used to improve sensitivity when detecting low abundance yihQ protein?

When working with samples containing low levels of yihQ protein, several methodological approaches can enhance detection sensitivity:

• Signal Amplification Strategies:

  • Employ tyramide signal amplification (TSA) for immunohistochemistry or Western blot

  • Use polymer-based detection systems with multiple secondary antibodies and enzyme molecules

  • Consider quantum dot-conjugated secondary antibodies for fluorescence applications

• Sample Enrichment Techniques:

  • Concentrate bacteria from large sample volumes by filtration or centrifugation

  • Use immunoprecipitation to enrich for yihQ before analysis

  • Employ subcellular fractionation to concentrate periplasmic proteins where yihQ may be localized

• Enhanced Detection Methods:

  • Utilize chemiluminescent substrates with extended signal duration

  • Consider digital immunoassay platforms (e.g., Simoa) for single-molecule detection

  • Implement sandwich ELISA with two different antibodies (requires a second antibody targeting a different epitope)

• Optimization Protocol for Western Blot Detection:

  Enhanced Protocol:

  • Sample preparation: Include protease inhibitors and maintain cold temperatures

  • Increase protein loading (50-100 μg total protein)

  • Use PVDF membranes (higher protein binding capacity than nitrocellulose)

  • Extend primary antibody incubation (overnight at 4°C)

  • Include 0.05% SDS in antibody dilution buffer to reduce background

  • Use high-sensitivity chemiluminescent substrate with signal enhancers

  • Extend exposure time when imaging

How can researchers validate novel applications of yihQ antibody beyond manufacturer-tested uses?

When extending the use of yihQ antibody to novel applications beyond those validated by manufacturers (ELISA and Western blot) , researchers should implement a systematic validation approach:

• Preliminary Application Assessment:

  • Begin with small-scale pilot experiments

  • Include all necessary controls (as outlined in section 3.1)

  • Compare results with established applications as reference points

• Optimization Protocol for Immunofluorescence:

  • Test multiple fixation methods (4% PFA, methanol, acetone)

  • Evaluate different permeabilization conditions (0.1-0.5% Triton X-100, saponin)

  • Titrate antibody concentration (typical range: 1-10 μg/ml)

  • Test various blocking solutions (BSA, serum, commercial blockers)

  • Compare signal-to-noise ratios across conditions

• Verification Through Multiple Methods:

  • Confirm findings using complementary techniques

  • For localization studies, compare immunofluorescence with subcellular fractionation followed by Western blot

  • For protein-protein interactions, validate co-immunoprecipitation results with proximity ligation assays

• Genetic and Biochemical Validation:

  • Generate knockout controls or siRNA knockdown samples

  • Use purified recombinant protein as positive control

  • Perform peptide competition assays to confirm specificity

• Inter-laboratory Validation:

  • Collaborate with other researchers to replicate key findings

  • Compare results across different antibody lots

  • Document all validation steps according to antibody reporting standards

This structured approach enhances confidence in novel applications and contributes to improved reproducibility in yihQ research, addressing concerns about antibody specificity highlighted in recent initiatives for better antibody characterization .

How can yihQ antibody contribute to studies of bacterial adaptation to sulfur-limited environments?

The yihQ antibody can be instrumental in investigating how bacteria adapt to environments where sulfur is a limiting nutrient. Methodological approaches include:

• Expression Analysis Under Sulfur Limitation:

  • Culture E. coli under sulfur-replete and sulfur-limited conditions

  • Harvest cells at different time points during adaptation

  • Quantify yihQ protein levels by Western blot or quantitative immunofluorescence

  • Correlate protein expression with transcriptomic data

  • Design a time-course experiment to track expression changes during adaptation

• Comparative Community Analysis:

  • Collect samples from environments with varying sulfur availability

  • Quantify yihQ-expressing bacteria using immunofluorescence microscopy

  • Compare abundance patterns across environmental gradients

  • Correlate with sulfoquinovose availability in the same environments

• Competition Experiments:

  • Set up mixed cultures of wildtype and yihQ-knockout strains

  • Grow under conditions where sulfoquinovose is the primary sulfur source

  • Track population dynamics using immunostaining and flow cytometry

  • Calculate competitive indices under different nutrient conditions

• Localization Studies During Nutrient Stress:

  • Examine potential changes in subcellular localization of yihQ under stress

  • Use co-localization with membrane markers to assess potential association with transport systems

  • Implement super-resolution microscopy to precisely map protein distribution

These approaches can reveal how the ability to utilize sulfoquinovose as a sulfur source contributes to bacterial fitness in various ecological niches, building on the finding that degradation of sulfoquinovosides is more widespread than previously thought .

What techniques can be used to study potential conformational changes in yihQ upon substrate binding?

Understanding conformational dynamics of yihQ upon substrate binding can provide insights into its catalytic mechanism. Researchers can employ these methodological approaches:

• Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):

  • Compare hydrogen-deuterium exchange patterns in free yihQ versus substrate-bound enzyme

  • Identify regions with altered solvent accessibility

  • Map these regions onto the crystal structure

  • Develop time-course experiments to capture transient conformational states

• Single-Molecule FRET:

  • Engineer yihQ variants with strategically placed fluorophores

  • Monitor distance changes between fluorophores upon substrate binding

  • Analyze energy transfer efficiency to detect conformational changes

  • Design constructs to focus on specific domains predicted to move

• Epitope Accessibility Analysis:

  • Use a panel of yihQ antibodies targeting different regions

  • Compare antibody binding before and after substrate addition

  • Regions showing altered antibody accessibility likely undergo conformational changes

  • Implement flow cytometry or ELISA-based detection for quantitative analysis

• Circular Dichroism Spectroscopy:

  • Record CD spectra of yihQ with and without substrate

  • Analyze changes in secondary structure content

  • Perform thermal denaturation studies to assess substrate-induced stabilization

  • Compare wildtype with catalytically inactive mutants (e.g., D472N )

The crystal structure of yihQ D472N in complex with PNPSQ provides a foundation for these studies, enabling targeted investigation of regions predicted to undergo conformational changes during catalysis.

How can researchers use yihQ antibody to investigate potential interacting partners of the enzyme?

Identifying protein-protein interactions involving yihQ can reveal insights into its cellular regulation and broader metabolic integration. Methodological approaches include:

• Co-Immunoprecipitation with Mass Spectrometry:

  • Lyse bacterial cells under gentle conditions

  • Immunoprecipitate yihQ using the specific antibody

  • Analyze co-precipitated proteins by LC-MS/MS

  • Filter results against appropriate controls (IgG, pre-immune serum)

  • Validate hits by reverse co-IP or alternative methods

  Protocol optimizations:

  • Test different lysis buffers (varying salt concentration, detergents)

  • Consider crosslinking to capture transient interactions

  • Include phosphatase inhibitors to preserve regulatory phosphorylation sites

• Proximity-Dependent Labeling:

  • Generate fusion proteins of yihQ with BioID or APEX2

  • Express in E. coli and activate labeling

  • Purify biotinylated proteins

  • Identify by mass spectrometry

  • Compare interactome under different growth conditions

• Bimolecular Fluorescence Complementation (BiFC):

  • Create fusion constructs of yihQ and candidate interactors with split fluorescent protein fragments

  • Express in bacteria and monitor fluorescence complementation

  • Quantify signal intensity as a measure of interaction strength

  • Validate with mutant controls that disrupt predicted interaction surfaces

• Antibody-Based Protein Microarrays:

  • Print arrays of potential bacterial interaction partners

  • Probe with purified yihQ

  • Detect bound yihQ using the specific antibody

  • Identify novel interactions through signal analysis

  • Follow up on candidates with orthogonal methods